Time Trends in Therapies and Outcomes for Adult Inflammatory Bowel Disease, Northern California, 1998–2005

Author:

Herrinton Lisa J.,Liu Liyan,Fireman Bruce,Lewis James D.,Allison James E.,Flowers Nicole,Hutfless Susan,Velayos Fernando S.,Abramson Oren,Altschuler Andrea,Perry Geraldine S.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference32 articles.

1. The European Panel on the Appropriateness of Crohn's Disease Therapy;Caprilli;Digestion,2005

2. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission;Sandborn;Aliment Pharmacol Ther,2007

3. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention;Sandborn;Rev Gastroenterol Disord,2006

4. Azathioprine for maintaining remission of Crohn's disease;Pearson;Cochrane Database Syst Rev.,2000

5. Infliximab in Crohn's disease: first anniversary clinical experience;Cohen;Am J Gastroenterol,2000

Cited by 87 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3